BPMC - Blueprint Medicines Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 53.98B
Enterprise Value 32.93B
Trailing P/E N/A
Forward P/E 1-10.37
PEG Ratio (5 yr expected) 1-0.32
Price/Sales (ttm)89.41
Price/Book (mrq)7.93
Enterprise Value/Revenue 365.81
Enterprise Value/EBITDA 6-12.07

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-554.86%

Management Effectiveness

Return on Assets (ttm)-24.59%
Return on Equity (ttm)-45.38%

Income Statement

Revenue (ttm)44.52M
Revenue Per Share (ttm)1.01
Quarterly Revenue Growth (yoy)-36.50%
Gross Profit (ttm)-199.1M
EBITDA -242.78M
Net Income Avi to Common (ttm)-236.64M
Diluted EPS (ttm)-5.39
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)494.01M
Total Cash Per Share (mrq)11.2
Total Debt (mrq)N/A
Total Debt/Equity (mrq)0.06
Current Ratio (mrq)8.28
Book Value Per Share (mrq)9.52

Cash Flow Statement

Operating Cash Flow (ttm)-175.01M
Levered Free Cash Flow (ttm)-107.01M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.67
52-Week Change 3-0.88%
S&P500 52-Week Change 311.15%
52 Week High 389.00
52 Week Low 344.58
50-Day Moving Average 381.02
200-Day Moving Average 368.50

Share Statistics

Avg Vol (3 month) 3458k
Avg Vol (10 day) 3447.82k
Shares Outstanding 552.75M
Float 43.51M
% Held by Insiders 11.45%
% Held by Institutions 195.00%
Shares Short (Mar 29, 2019) 42.56M
Short Ratio (Mar 29, 2019) 44.38
Short % of Float (Mar 29, 2019) 46.93%
Short % of Shares Outstanding (Mar 29, 2019) 45.81%
Shares Short (prior month Feb 28, 2019) 42.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A